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Summary It is well known that there might be an epidemiological association
between Helicobacter pylori infection and extraintestinal diseases. This study aimed
at determining H. pylori infection in epileptic patients. Forty-seven cryptogenic
epileptic patients (Group 1) and 35 healthy people (Group 2) participated in this study.
Presence of H. pylori infection was examined by H. pylori stool antigen (HpSA), H.
pylori IgG, and IgM. HpSA was detected in 21 participants (44.6%) in Group 1 and in 3
participants (8.5%) in Group 2. H. pylori IgM was positive in 27 participants (57.4%) in
Group 1 and in 8 participants (22.8%) in Group 2. H. pylori IgG was positive in 37
participants (78.7%) in Group 1 and in 13 participants (38%) in Group 2. The difference
of rates of HpSA, H. pylori IgM and IgG in Groups 1 and 2 were found statistically
significant (x2 = 4.18, p = 0.04; x2 = 9.18, p = 0.0017; x2 = 14.58, p < 0.001, respec-
tively). We also compared presence of H. pylori infection between the epileptic
patients with poor and good prognosis; HpSA positivity was detected in 15 (62.5%) of
24 and 6 (26%) of 23, respectively, and the differences were statistically significant
(x2 = 6.30, p = 0.012). H. pylori IgM positivity was detected in 16 (66%) of 24 patients
with poor prognosis and 11 (47.8%) of 23 patients with good prognosis ( p > 0.05). H.
pylori IgG positivity was detected in 18 (75%) of 24 patients with poor prognosis and 19
(82.6%) of 23 patients with good prognosis. The differences of H. pylori IgM and IgG
positivity rates in epileptic patients with poor and good prognosis were not found
statistically significant ( p > 0.05). These results suggest a probable association
between the acute H. pylori infection and epilepsy, especially with poor prognosis.
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Helicobacter pylori causes chronic infection in a
large proportion of the world’s population1 and it
is associated with a number of different clinical
conditions. These include gastritis, gastric and duo-
denal ulcers, gastric adenocarcinoma, and mucosa-
associated lymphoid tissue lymphoma.2 Recent
studies suggest the possible role of H. pylori infec-
tion in extra intestinal diseases, such as thrombo-
cytopenic purpura, iron deficiency anemia,
epilepsy, various dermatological disorders, and Alz-
heimer disease.3—9 The cause of H. pylori infection
on extra intestinal diseases could be an immunolo-
gical mechanisms response to either an antigen
released during tissue destruction or an infective
agent. Mehmet et al.10 reported that the concen-
trations of total nitrite and nitrate and cytokines
(TNF-alpha, IL-2R, IL-6, and IL-8) in gastric fluids
and sera of H. pylori-positive gastric cancer
patients were higher than H. pylori-negative con-
trol groups. This effect of H. pylori on markers of
inflammation, such as fibrinogen and leukocyte
count, may be mediated via certain cytokines,
including interleukin-6 and tumor necrosis factor
(TNF-alpha). Concentrations of this cytokine are
increased in the gastric mucosa of H. pylori positive
infected patients.11
The brain is a symptom-producing organ, and one
of the symptoms due to a basic brain dysfunction is
epilepsy. The pathophysiologic background is multi-
factorial in most epilepsy, as different pre-, peri-,
and postnatal triggers or environmental conditions
influence one or several genetic factors, where also
gender is of importance. One of the genetic factors
is immunodysfunction, and the trigger mechanism
may be a virus, a parasitic, or a bacterial infec-
tion.3,12—14 It has been reported that immunological
mechanisms might play a role in the pathogenesis of
seizure disorders.15,16 This study was conducted to
identify the presence of H. pylori infection at epi-
leptic patients and its relationship with poor prog-
nosis.Materials and methods
In the present study, two populations were com-
pared: Group 1 and Group 2. Group 1 (the experi-
mental group) consisted of 47 cryptogenic epileptic
patients. Group 2 (the control group) consisted of 35
healthy people. Epilepsy patients, who attended to
the Department of Neurology of Duzce School of
Medicine between 2000 and 2004, participated in
this study. These epileptic outpatients were con-
tacted during their periodic check ups betweenJanuary 2000 and June 2004. Epidemiological data
determining the socioeconomic status of the Groups
1 and 2 participants were collected by a paper and
pencil questionnaire. Clinical records were exam-
ined on the history of antiepileptic medication, the
time of onset and prognosis, and the type of epi-
leptic syndrome according to The International Clas-
sification of Epilepsies and Epileptic Syndromes. A
standardized questionnaire for poor prognostic
characteristics, medical history (the date of first
epileptic attack and the frequency of attacks), and
subjective symptoms, was administered to all
patients. Patients’ socioeconomic levels were char-
acterized using two factors: (a) the averagemonthly
income per person and (b) the living space per
person (in square meters) in their residential areas
(e.g., homes, apartments and townhouses). Neuro-
logical examination for each individual was per-
formed and the physical findings were recorded.
Epilepsy with good prognosis, free from seizures
for the last 3 years, was taken into consideration.
The Ethical Committee of the Abant Izzet Baysal
University, Duzce School of Medicine Hospital has
approved this study and the informed consent was
obtained from the participants prior to the data
collection.
Prospective collection of clinical and microbio-
logic data was obtained from the individuals in
Groups 1 and 2. Stool and blood samples were
obtained to detect the presence of H. pylori infec-
tion. Fecal samples, obtained from both groups,
were examined for determination of H. pylori stool
antigen. Additionally, blood samples of all partici-
pants were tested for determination of H. pylori
antibody (IgM and IgG). The stool samples were
placed into a tube containing 200 ml of sample
diluents and they were stored at (20 8C) until
the assay was performed. The H. pylori stool anti-
gen (HpSA) EIA test (Premier Platinum, Meridien
Diagnostis, USA) was used for the detection of the
H. pylori antigen from stool samples. H. pylori IgM
enzyme-linked immunosorbent assay (ELISA)
(Ridascreen H. pylori IgM, r-biopharm, Dormstart,
Germany) antibody test,H. pylori IgG ELISA (Ridasc-
reen H. pylori IgG, r-biopharm) antibody test were
used for the detection of H. pylori antibody from
blood samples.
Statistical analysis
We conducted statistical analysis using SPSS 11.0 for
Windows 98. Numerical data were analyzed with
Independent Sample t-test. Chi-square and Fisher’s
exact probability tests were applied for the cate-
gorical data. A p-value that is equal to or less than
0.05 was considered statistically significant.
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Table 1 Characteristics of the Groups 1 and 2 parti-
cipants
Total (n) Female Male Mean age
Group 1 47 25 (53%) 22 (47%) 32.74  9.2
Group 2 35 15 (43%) 20 (57%) 28.25  5.8Results
Groups 1 and 2 comprised 47 cryptogenic epileptic
patients and 35 healthy persons, respectively
(Table 1). Of the Group 1, 25 participants were
female (53%) and 22 were male (47%). The Group
1 participants’ ages ranged from 15 to 75 years old
(mean: 32.74  15.13). Of the Group 2, 15 partici-
pants were female (43%) and 20 were male (57%).
These participants’ ages in Group 2 ranged from 16
to 35 years old (mean: 28.25  5.8).
The epidemiologic and social factors in Groups 1
and 2 are shown in Table 2. Monthly income per
person, mean household size, and the living space
per person at a residential were investigated for
both groups. Groups were found as at the same level
of socioeconomic status.
H. pylori stool antigenwere detected in 21 (44.6%)
of Group 1 and in 3 (8.5%) of Group 2. H. pylori IgM
were positive in 27 (57.4%) of Group 1 and in 8 (22.8%)
of Group 2. H. pylori IgG were positive in total 37
(78.7%) of Group 1 and in 13 (38%) of Group 2. TheTable 2 Results regarding the epidemiologic and social fa
Investigated parameters Group 1 (n, 47)
Monthly income per person Mediana: US$ 13,30
(minimum: 43, max
Mean household size 4 (1) people
Living space (m2) per person at home Mediana: 23 m2
(minimum: 15, max
a Because of non-parametric distribution variable presented on m
Table 3 HpSA, H. pylori IgG and H. pylori IgM positivity in
Group 1 (total: 47) n (%)
HpSA positivity 21 (44.6)
H. pylori IgM positivity 27 (57.4)
H. pylori IgG positivity 37 (78.7)
Table 4 Characteristics and distributions of the epileptic
The age groups
of the patients
(years)
The number of
the patients total
(male, female)
The numbe
of patient
HpSA posit
10—29 20 (8—12) 8 (40%)
30—49 11 (6—5) 7 (63%)
50—79 16 (8—8) 6 (37.5%)differences of HpSA, H. pylori IgM and H. pylori IgG
positivity rates between Groups 1 and 2 were found
statistically significant (x2 = 4.18,p = 0.04;x2 = 9.18,
p = 0.0017; x2 = 14.58, p < 0.001, respectively).
These results are represented in Table 3.
Based on the questionnaire responses, patients
were categorized as their age groups and their
epileptic disorder period. Three age groups were
crafted: ‘‘10—29’’ (n = 20), ‘‘30—49’’ (n = 11), and
‘‘50—79’’ (n = 16). The rates of HpSA positivity for
these age groups were 8 (40%), 7 (63%), and 6
(37.5%), respectively. The rates of anti-H. pylori
IgM positivity were 15 (75%), 4 (36.4%), and 8
(50%) and the rates of anti-H. pylori IgG positivity
were 14 (70%), 8 (72.7%), 14 (87.5%). The difference
between presence of H. pylori infection and age
groups of the patients were not found statistically
significant (p > 0.05). The characteristics and dis-
tributions of the epileptic patients are shown in
Table 4.
The Group 1 participants were grouped into three
sub-categories based upon the duration of their
epilepsy: ‘‘0—5 years’’ (n = 23), ‘‘6—11 years’’
(n = 7), and ‘‘12 years and more’’ (n = 17). The
relationship between the duration of epilepsy and
H. pylori infection was examined. The difference
between presence of H. pylori infection and dura-
tion of the epilepsy was not found statistically sig-
nificant (p > 0.05). The relationship between thectors in Groups 1 and 2
Group 2 (n, 35) p-Value
0
imum: 461)
Mediana: US$ 12,000
(minimum: 39, maximum: 510)
>0.05
5 (1) people >0.05
imum: 75)
Mediana: 27 m2
(minimum: 17, maximum: 80)
>0.05
edian (minimum—maximum).
Groups 1 and 2
Group 2 (total: 35) n (%) x2 and p-value
3 (8.5) x2 = 4.18, p = 0.0400
8 (23) x2 = 9.18, p = 0.0017
13 (38) x2 = 14.58, p < 0.001
patients (Group 1)
r
s having
ivity
The number of
patients having
HpIgM positivity
The number of
patients having
HpIgG positivity
15 (75%) 14 (70%)
4 (36.4%) 8 (72.7%)
8 (50%) 14 (87.5%)
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Table 5 The relationship between the duration of epileptic disorder and H. pylori infection
The duration of
epilepsy (year)
Number of
the patients
HpSA ( p > 0.05) Hp IgM ( p > 0.05) Hp IgG ( p > 0.05)
(+) () (+) () (+) ()
0—5 23 10 (44%) 13 (46%) 15 (65%) 8 (35%) 18 (78%) 5 (22%)
6—11 7 2 (29%) 5 (71%) 6 (85%) 1 (15%) 5 (71%) 2 (29%)
>12 17 9 (53%) 8 (47%) 14 (82%) 3 (18%) 14 (82%) 3 (18%)
Table 6 HpSA, H. pylori IgM and H. pylori IgG positivity in epileptic patients (Group 1) with poor and good prognosis
Epileptic patients
with poor prognosis
(total: 24) n (%)
Epileptic patients
with good prognosis
(total: 23) n (%)
x2 and p-value
HpSA positivity 15 (62.5) 6 (26) x2 = 6.30; p = 0.012
H. pylori IgM 16 (66) 11 (47.8) p > 0.05
H. pylori IgG 18 (75) 19 (82) p > 0.05duration of epilepsy and H. pylori infection for the
Group 1 participants are summarized in Table 5.
We also compared the presence of H. pylori
infection among the patients with poor prognosis
and good prognosis. Of these 47 epileptic patients,
24 (50%) showed poor prognosis and 23 (50%) showed
good prognosis. HpSA positivity was detected in 15
(62.5%) of 24 patients with poor prognosis and 6
(26%) of 23 patients with good prognosis. The dif-
ference of HpSA positivity rates in epileptic patients
with poor and good prognosis was found statistically
significant (x2 = 6.30; p = 0.012). H. pylori IgM posi-
tivity was detected in 16 (66%) of 24 patients with
poor prognosis and 11 (47.8%) of 23 patients with
good prognosis ( p > 0.05). The differences of H.
pylori IgM and H. pylori IgG positivity rates in epi-
leptic patients with poor and good prognosis were
not found statistically significant. H. pylori IgG
positivity was detected in 18 (75%) of 24 patients
with poor prognosis and 19 (82.6%) of 23 patients
with good prognosis (p > 0.05). These results were
shown in Table 6.Discussion
The relationship with extra-intestinal diseases and
chronic H. pylori infections is known. This relation-
ship is probably associated with immunological
mechanisms. Seizures may be triggered by immuno-
logical mechanisms due to H. pylori infections. That
immunological mechanisms, whichmay play a role in
the pathogenesis of seizure disorders, was first pro-
posed by Walker.17 Karpiak et al.15 studied seizure
induction in rats by antibodies against brain ganglio-
sides. Ettlinger and Lowrie16 put forward the hypoth-
esis that epileptic discharges could be the result of an
autoimmune response to either an antigen releasedduring tissue destruction, or an infective agent. Bar-
tolomei et al.18 found anti-GM1 antibodies in human
cryptogenic focal epilepsies, and suggested a new
form of immune-mediated epilepsy. Turrin et al.19
suggest a different mechanism involved in regulating
the innate immune reaction in response to seizures
and this mechanism could have direct implications
for the neuropathology associated with epilepsy.
Although pro-inflammatory markers were induced
in a different manner across the central nervous
system (CNS), their patterns were not characteristic
of those caused by other inflammatory challenges,
such as endotoxin. Inflammatory signals have also
been reported in clinical cases of epilepsy20 and
immune molecules have already been associated
with predisposition to epilepsy.21 Recent studies
reported some probable relationships between H.
pylori infection and neurological diseases as Alzhei-
mer disease (AD), acute inflammatory demyelinating
polyradiculoneuropathy.9,22,23 Kountouras et al.9
investigated the association betweenH. pylori infec-
tion and AD. They found that the rate of H. pylori
infection in AD patients is higher than the ones in
control group. They emphasized that H. pylori infec-
tionmay influence thepathophysiology of AD through
oneof the followingmechanisms: plateletactivation,
releasing large amounts of pro-inflammatory and
vasoactive substances, such as cytokines (interleukin
[IL]-1, IL-6, IL-8, IL-10, IL-12, tumor necrosis factor-
alpha, interferon-gamma), eicosanoids (leuko-
trienes, prostaglandins catalyzed by cyclooxygenase
enzymes), and acute phase proteins (fibrinogen,
C-reactive protein), causing the development of
crossmimicry between endothelial andHp antigens.,
producing reactive oxygen metabolites and circulat-
ing lipid peroxides.
Okuda et al.3 investigated the rate of H. pylori
infection in epileptic patient and its influence on
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out H. pylori infection showed good prognosis. They
proposed that H. pylori infection, possibly through
production by anticardiolipin antibodies, is involved
in some cases of epilepsy.
In the present study, the presence of H. pylori
infection in epileptic patients was investigated for
the possible trigger effect of seizure via immunolo-
gical mechanisms. We preferred non-invasive meth-
ods to investigate H. pylori infection. H. pylori
antibody (IgM and IgG) from blood samples and HpSA
from stool samples were analyzed. Since there is
evidence that infected individuals excrete H. pylori
in feces, an enzyme immunoassay (EIA, HpSA) has
been developed that can detect H. pylori antigen in
human feces during active infection.24 Therefore, it
is non-invasive; HpSA immunoassay would be parti-
cularly important for patients for whom endoscopy
is not clinically indicated. The sensibility and spe-
cificity of HpSA are reported 100 and 97%, respec-
tively.25
In our study, we particularly looked at to the
groups of people who were at similar ages and
had similar socioeconomic status. The average
monthly income and the living space per person in
a residential area were considered as factors iden-
tifying the socioeconomic status (see Table 2 for
details). The t-test analysis revealed that the means
of monthly income and the living space for Groups 1
and 2 participants were not significantly different
from one another. We compared Groups 1 and 2
based upon the H. pylori infection rate. In Group
1, we observed higher rates of H. pylori infection
than the Group 2. HPSA and H. pylori IgM tests were
the criteria of active infection and were higher in
Group 1 compared to Group 2. The rate of HpSA
positivity was higher in patients with poor prognosis
rather than good prognosis, demonstrating the influ-
ence of poor prognosis. Our findings reveal that H.
pylori infections might trigger epilepsy by immuno-
logic mechanisms as also shown in previous studies.
Therefore, we suggest that H. pylori infection
should be investigated at epileptic patients, espe-
cially the patients with poor prognosis. HpSa tests
that are easy to run can be used to identify active H.
pylori infections at those patients.
However, the relevant studies published so far
are few in number and they involve small series of
patients. Further studies are needed especially with
more participants.References
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